VYNE: vynetherapeutics.com Cash Calculated per Single Share

VYNE Therapeutics Inc. - graphic logo of issuer VYNE

This free cash flow per share chart demonstrates the liquidity of VYNE Therapeutics (VYNE), where the 28.92 level captures the current state. The biopharma company utilizes unique MST technology to create fast-absorbing foam for psoriasis. The company plans to generate revenue through the implementation of innovative therapy methods for immuno-inflammatory pathologies. Stability of chemical raw material supplies is ensured via diversified routes and strict temperature control.

VYNE Therapeutics, Inc. (VYNE) - Cash per Share from 07/04/2022 to 07/28/2026

Comprehensive metric breakdowns and analytics for VYNE Therapeutics Inc (VYNE)

- cash availability and cash flow indicators:
Comprehensive company analysis:VYNE Therapeutics Inc. (VYNE)
Flagship merchandise of VYNE Therapeutics, Inc.

Long-term investing requires strict liquidity control to minimize capital risks. Stable capacity utilization at VYNE (VYNE) for the production of dermatological agents necessitates constant financial support. This cash per share chart reflects the ratio of total cash balance to the number of issued securities. Growth in this indicator confirms the company's stability, although excess funds may reduce overall profitability. This metric determines the actual value of the liquid reserve on a per-share basis.